Literature DB >> 19172434

HIV and HCV discordant injecting partners and their association to drug equipment sharing.

Prithwish De1, Joseph Cox, Jean-Francois Boivin, Robert W Platt, Ann M Jolly, Paul E Alexander.   

Abstract

Our objective was to examine the association between HIV and HCV discordant infection status and the sharing of drug equipment by injection drug users (IDUs). IDUs were recruited from syringe exchange and methadone treatment programmes in Montreal, Canada. Characteristics of participants and their injecting partners were elicited using a structured questionnaire. Among 159 participants and 245 injecting partners, sharing of syringes and drug preparation equipment did not differ between concordant or discordant partners, although HIV-positive subjects did not share with HIV-negative injectors. Sharing of syringes was positively associated with discordant HIV status (OR=1.85) and negatively with discordant HCV status (OR=0.65), but both results were not statistically significant. Sharing of drug preparation equipment was positively associated with both discordant HIV (OR=1.61) and HCV (OR=1.18) status, but both results were non-significant. Factors such as large injecting networks, frequent mutual injections, younger age, and male gender were stronger predictors of equipment sharing. In conclusion, IDUs do not appear to discriminate drug equipment sharing partners based at least on their HCV infection status. The results warrant greater screening to raise awareness of infection status, post-test counselling to promote status disclosure among partners, and skill-building to avoid equipment sharing between discordant partners.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19172434      PMCID: PMC2929251          DOI: 10.1080/00365540902721376

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  27 in total

1.  Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. European Community Study Group on HIV in Injecting Drug Users.

Authors:  M G Schlumberger; J C Desenclos; G Papaevangelou; S C Richardson; R Ancelle-Park
Journal:  Eur J Epidemiol       Date:  1999-03       Impact factor: 8.082

2.  HIV risk behaviors associated with the injection process: multiperson use of drug injection equipment and paraphernalia in injection drug user networks.

Authors:  R H Needle; S Coyle; H Cesari; R Trotter; M Clatts; S Koester; L Price; E McLellan; A Finlinson; R N Bluthenthal; T Pierce; J Johnson; T S Jones; M Williams
Journal:  Subst Use Misuse       Date:  1998-10       Impact factor: 2.164

3.  The prevalence of additional injection-related HIV risk behaviors among injection drug users.

Authors:  S Koester; R E Booth; Y Zhang
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-06-01

4.  Towards an understanding of risk behavior: an AIDS risk reduction model (ARRM).

Authors:  J A Catania; S M Kegeles; T J Coates
Journal:  Health Educ Q       Date:  1990

5.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

6.  Friends and lovers: needle sharing in young people in Western Australia.

Authors:  W Loxley; C Ovenden
Journal:  AIDS Care       Date:  1995

7.  Changes in the injecting risk behaviour of injecting drug users in London, 1990-1993.

Authors:  G M Hunter; M C Donoghoe; G V Stimson; T Rhodes; C P Chalmers
Journal:  AIDS       Date:  1995-05       Impact factor: 4.177

8.  Evaluation of interviewing techniques to enhance recall of sexual and drug injection partners.

Authors:  D D Brewer; S B Garrett
Journal:  Sex Transm Dis       Date:  2001-11       Impact factor: 2.830

9.  Drug-related behavior change for HIV transmission among American injection drug users.

Authors:  D D Celentano; A Muñoz; S Cohn; K E Nelson; D Vlahov
Journal:  Addiction       Date:  1994-10       Impact factor: 6.526

10.  Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland.

Authors:  Danielle C Ompad; Crystal M Fuller; David Vlahov; David Thomas; Steffanie A Strathdee
Journal:  Clin Infect Dis       Date:  2002-09-03       Impact factor: 9.079

View more
  9 in total

1.  The influence of a peer-based HIV prevention intervention on conversation about HIV prevention among people who inject drugs in Baltimore, Maryland.

Authors:  Aleksandra Mihailovic; Karin Tobin; Carl Latkin
Journal:  AIDS Behav       Date:  2015-10

2.  Development and validation of a novel scale for measuring interpersonal factors underlying injection drug using behaviours among injecting partnerships.

Authors:  Meghan D Morris; Torsten B Neilands; Erin Andrew; Lisa Maher; Kimberly A Page; Judith A Hahn
Journal:  Int J Drug Policy       Date:  2017-08-09

3.  The STEP into Action study: a peer-based, personal risk network-focused HIV prevention intervention with injection drug users in Baltimore, Maryland.

Authors:  Karin Elizabeth Tobin; Satoko Janet Kuramoto; Melissa Ann Davey-Rothwell; Carl Asher Latkin
Journal:  Addiction       Date:  2010-11-04       Impact factor: 6.526

4.  Infection disclosure in the injecting dyads of Hungarian and Lithuanian injecting drug users who self-reported being infected with hepatitis C virus or human immunodeficiency virus.

Authors:  V Anna Gyarmathy; Alan Neaigus; Nan Li; Eszter Ujhelyi; Irma Caplinskiene; Saulius Caplinskas; Carl A Latkin
Journal:  Scand J Infect Dis       Date:  2010-09-15

5.  Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.

Authors:  Judith A Hahn; Jennifer L Evans; Peter J Davidson; Paula J Lum; Kimberly Page
Journal:  Addiction       Date:  2010-05-14       Impact factor: 6.526

6.  A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Montreal, Canada.

Authors:  Ehsan Jozaghi; Andrew A Reid; Martin A Andresen
Journal:  Subst Abuse Treat Prev Policy       Date:  2013-07-09

7.  Age and sharing of needle injection equipment in a cohort of Massachusetts injection drug users: an observational study.

Authors:  Katherine Tassiopoulos; Judith Bernstein; Edward Bernstein
Journal:  Addict Sci Clin Pract       Date:  2013-12-13

8.  Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA.

Authors:  Meghan D Morris; Jennifer Evans; Martha Montgomery; Michelle Yu; Alya Briceno; Kimberly Page; Judith A Hahn
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

Review 9.  Social values for health technology assessment in Canada: a scoping review of hepatitis C screening, diagnosis and treatment.

Authors:  Caroline O'Keefe-Markman; Kristina Dawn Lea; Christopher McCabe; Elaine Hyshka; Tania Bubela
Journal:  BMC Public Health       Date:  2020-01-20       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.